Haisco Pharmaceutical Hits Day High with 8.2% Surge in Stock Price

Haisco Pharmaceutical Group Co., Ltd. has experienced significant activity today, with the stock rising by 8.2% as of March 10, 2026. The stock reached an intraday high of CNY 49.89, reflecting a strong performance compared to the broader market, as the China Shanghai Composite index only increased by 0.65% on the same day. Over the past week, Haisco has shown a remarkable gain of 10.05%, while its one-year performance stands at an impressive 47.32%, outpacing the China Shanghai Composite's 22.49% return. However, year-to-date, the stock has seen a decline of 3.55%, contrasting with the composite's positive performance of 3.89%. Despite these fluctuations, Haisco's long-term growth metrics indicate a more cautious outlook, with net sales growing at an annual rate of 5.08% over the last five years. The company currently holds a market capitalization of CNY 25,698 million and maintains a price-to-earnings ratio of 141.00, suggesting a premium valuation in the pharmaceuticals and biotechnology sector.